Servicing Academia, Biotech, and the Pharmaceutical Industry
Overview
Probetex, Inc. is a life science and contract research organization (CRO) founded in 1997, The company lists six specialization areas including 1) A cell bank of adult and embryonic kidney cell lines; 2) Production and sale of sheep nephrotoxic antibodies to induce anti-glomerular basement membrane (anti-GBM) glomerulonephritis, membranous nephropathy (anti-Fx1A), and mesangioproliferative (anti-Thy1) glomerulonephritis models of disesae. 3) Tissue products from renal disease models; 4) Histopathology services providing routine histology, immunohistochemistry, electron microscopy and image analysis; 5) Custom contract research specializing in the above models as well as over 20 other models of acute and chronic experimental kidney disease, cardiovascular liver and lung disease; and 6) other specialty areas such as regenerative medicine and an initiative to raise funds for the development of new models of anti-neutrophil cytoplasmic antibody vasculitis (ANCA). Probetex also assists in the assessment and development of rare disease models.
(see Probetex publications)
Overview
Probetex, Inc. is a life science and contract research organization (CRO) founded in 1997, The company lists six specialization areas including 1) A cell bank of adult and embryonic kidney cell lines; 2) Production and sale of sheep nephrotoxic antibodies to induce anti-glomerular basement membrane (anti-GBM) glomerulonephritis, membranous nephropathy (anti-Fx1A), and mesangioproliferative (anti-Thy1) glomerulonephritis models of disesae. 3) Tissue products from renal disease models; 4) Histopathology services providing routine histology, immunohistochemistry, electron microscopy and image analysis; 5) Custom contract research specializing in the above models as well as over 20 other models of acute and chronic experimental kidney disease, cardiovascular liver and lung disease; and 6) other specialty areas such as regenerative medicine and an initiative to raise funds for the development of new models of anti-neutrophil cytoplasmic antibody vasculitis (ANCA). Probetex also assists in the assessment and development of rare disease models.
(see Probetex publications)
Mission
Probetex's mission is to provide the highest quality products and services for the assessment of experimental disease. The company provides resources for the study of disease, often a decisive factor for those wishing to rapidly acquire preliminary or definitive data for drug discovery, pathobiology of disease, publications, grant applications or feasibility studies.